Global drugmakers will be allowed to label drugs directly at customs warehouses in Russia

30 July 2020
russia_moscow_large-1-

Global drugmakers operating in Russia will be able to label their drugs directly at customs warehouses in Russia, which will allow them to save on costs and facilitate imports of many of foreign drugs to the Russian market.

That has been recently approved by Russia’s Prime Minister Mikhail Mishustin, reports The Pharma Letter’s local correspondent. The introduction of the measure was part of state efforts for the launch of the all-Russian system of drug labeling.

Starting from July 1 of the current year, all the drugs produced in Russia must be labeled with Data Matrix codes, which means that information about their movement in the retail network will be recorded in the Russian Federal State Information System for Monitoring the Movement of Drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical